Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer. J Clin. 2021;71:209–49. https://doi.org/10.3322/caac.21660.
Article
Google Scholar
Barta JA, Powell CA, Wisnivesky JP. Global Epidemiology of Lung Cancer. Ann Glob Health 2019;85. https://doi.org/10.5334/aogh.2419.
Cooley ME. Symptoms in Adults with Lung Cancer: A Systematic Research Review. J Pain Symptom Manag. 2000;19:137–53. https://doi.org/10.1016/S0885-3924(99)00150-5.
Article
CAS
Google Scholar
Polanski J, Jankowska-Polanska B, Rosinczuk J, Chabowski M, Szymanska-Chabowska A. Quality of life of patients with lung cancer. Onco Targets Ther. 2016;9:1023–8. https://doi.org/10.2147/OTT.S100685.
Article
PubMed
PubMed Central
Google Scholar
Nelson EC, Eftimovska E, Lind C, Hager A, Wasson JH, Lindblad S. Patient reported outcome measures in practice. BMJ. 2015;350:g7818. https://doi.org/10.1136/bmj.g7818.
Article
PubMed
Google Scholar
Bouazza YB, Chiairi I, El Kharbouchi O, De Backer L, Vanhoutte G, Janssens A, et al. Patient-reported outcome measures (PROMs) in the management of lung cancer: A systematic review. Lung Cancer. 2017;113:140–51. https://doi.org/10.1016/j.lungcan.2017.09.011.
Article
PubMed
Google Scholar
Øvretveit J, Zubkoff L, Nelson EC, Frampton S, Knudsen JL, Zimlichman E. Using patient-reported outcome measurement to improve patient care. Int J Qual Health Care. 2017;29:874–9. https://doi.org/10.1093/intqhc/mzx108.
Article
PubMed
Google Scholar
Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, et al. Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial. JCO. 2016;34:557–65. https://doi.org/10.1200/JCO.2015.63.0830.
Article
CAS
Google Scholar
Denis F, Lethrosne C, Pourel N, Molinier O, Pointreau Y, Domont J, et al. Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients. JNCI: J Natl Cancer Inst. 2017;109:djx029. https://doi.org/10.1093/jnci/djx029.
Article
Google Scholar
Schmidt K, Damm K, Prenzler A, Golpon H, Welte T. Preferences of lung cancer patients for treatment and decision-making: a systematic literature review. Eur J Cancer Care (Engl). 2016;25:580–91. https://doi.org/10.1111/ecc.12425.
Article
CAS
Google Scholar
Moons KGM, Royston P, Vergouwe Y, Grobbee DE, Altman DG. Prognosis and prognostic research: what, why, and how? BMJ. 2009;338:b375. https://doi.org/10.1136/bmj.b375.
Article
PubMed
Google Scholar
Hemingway H, Croft P, Perel P, Hayden JA, Abrams K, Timmis A, et al. Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes. BMJ. 2013;346:e5595. https://doi.org/10.1136/bmj.e5595.
Article
PubMed
PubMed Central
Google Scholar
Kent P, Cancelliere C, Boyle E, Cassidy JD, Kongsted A. A conceptual framework for prognostic research. BMC Med Res Methodol. 2020;20:172. https://doi.org/10.1186/s12874-020-01050-7.
Article
PubMed
PubMed Central
Google Scholar
Craddock M, Crockett C, McWilliam A, Price G, Sperrin M, van der Veer SN, et al. Evaluation of Prognostic and Predictive Models in the Oncology Clinic. Clin Oncol (R Coll Radiol). 2022;34:102–13. https://doi.org/10.1016/j.clon.2021.11.022.
Article
CAS
Google Scholar
Sloan JA, Zhao X, Novotny PJ, Wampfler J, Garces Y, Clark MM, et al. Relationship Between Deficits in Overall Quality of Life and Non–Small-Cell Lung Cancer Survival. J Clin Oncol. 2012;30:1498–504. https://doi.org/10.1200/JCO.2010.33.4631.
Article
PubMed
PubMed Central
Google Scholar
Ediebah DE, Coens C, Zikos E, Quinten C, Ringash J, King MT, et al. Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial. Br J Cancer. 2014;110:2427–33. https://doi.org/10.1038/bjc.2014.208.
Article
CAS
PubMed
PubMed Central
Google Scholar
Efficace F, Collins GS, Cottone F, Giesinger JM, Sommer K, Anota A, et al. Patient-Reported Outcomes as Independent Prognostic Factors for Survival in Oncology: Systematic Review and Meta-Analysis. Value in Health. 2021;24:250–67. https://doi.org/10.1016/j.jval.2020.10.017.
Article
PubMed
Google Scholar
Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18:143. https://doi.org/10.1186/s12874-018-0611-x.
Article
PubMed
PubMed Central
Google Scholar
Peters MDJ, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. JBI Evid Implement. 2015;13:141–6. https://doi.org/10.1097/XEB.0000000000000050.
Article
Google Scholar
Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169:467–73. https://doi.org/10.7326/M18-0850.
Article
PubMed
Google Scholar
Zhou L, Wang X-L, Deng Q-L, Du Y-Q, Zhao N-Q. The efficacy and safety of immunotherapy in patients with advanced NSCLC: a systematic review and meta-analysis. Sci Rep. 2016;6:32020. https://doi.org/10.1038/srep32020.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nama V, Nordin A, Bryant A. Patient-reported outcome measures for follow‐up after gynaecological cancer treatment. Cochrane Database of Systematic Reviews. 2013. https://doi.org/10.1002/14651858.CD010299.pub2.
Article
PubMed
PubMed Central
Google Scholar
Ingui BJ, Rogers MAM. Searching for Clinical Prediction Rules in Medline. J Am Med Inform Assoc. 2001;8:391–7. https://doi.org/10.1136/jamia.2001.0080391.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jones GS, Baldwin DR. Recent advances in the management of lung cancer. Clin Med (Lond). 2018;18:s41–6. https://doi.org/10.7861/clinmedicine.18-2s-s41.
Article
Google Scholar
Zappa C, Mousa SA. Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016;5:288–300. https://doi.org/10.21037/tlcr.2016.06.07.
Article
CAS
PubMed
PubMed Central
Google Scholar
Qin H, Wang F, Liu H, Zeng Z, Wang S, Pan X, et al. New advances in immunotherapy for non-small cell lung cancer. Am J Transl Res. 2018;10:2234–45.
CAS
PubMed
PubMed Central
Google Scholar
Jenkins DA, Mohamed S, Taylor JK, Peek N, Veer SN van der. Potential prognostic factors for delayed healing of common, non-traumatic skin ulcers: A scoping review. Int Wound J. 2019;16:800–12. https://doi.org/10.1111/iwj.13100.
Article
PubMed
PubMed Central
Google Scholar
Hayden JA, van der Windt DA, Cartwright JL, Côté P, Bombardier C. Assessing Bias in Studies of Prognostic Factors. Ann Intern Med. 2013;158:280–6. https://doi.org/10.7326/0003-4819-158-4-201302190-00009.
Article
PubMed
Google Scholar
Grooten WJA, Tseli E, Äng BO, Boersma K, Stålnacke B-M, Gerdle B, et al. Elaborating on the assessment of the risk of bias in prognostic studies in pain rehabilitation using QUIPS—aspects of interrater agreement. Diagn Prognostic Res. 2019;3:5. https://doi.org/10.1186/s41512-019-0050-0.
Article
Google Scholar
Wolff RF, Moons KGM, Riley RD, Whiting PF, Westwood M, Collins GS, et al. PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies. Ann Intern Med. 2019;170:51–8. https://doi.org/10.7326/M18-1376.
Article
PubMed
Google Scholar
McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Research Synthesis Methods n.d.;n/a. https://doi.org/10.1002/jrsm.1411.
Agarwal JP, Chakraborty S, Laskar SG, Mummudi N, Arora J, Badhe R, et al. Prognostic value of a patient-reported functional score versus physicianreported Karnofsky Performance Status Score in brain metastases. Ecancermedicalscience. 2017;11:779.
Article
Google Scholar
Arraras JI, Hernandez B, Martinez M, Cambra K, Rico M, Illarramendi JJ, et al. Quality of Life in Spanish advanced non-small-cell lung cancer patients: determinants of global QL and survival analyses. SpringerPlus 2016;5.
Arrieta O, Angulo LP, Núñez-Valencia C, Dorantes-Gallareta Y, Macedo EO, Martínez-López D, et al. Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Ann Surg Oncol. 2013;20:1941–8. https://doi.org/10.1245/s10434-012-2793-5.
Article
PubMed
Google Scholar
Barney BJ, Wang XS, Lu C, Liao Z, Johnson VE, Cleeland CS, et al. Prognostic value of patient-reported symptom interference in patients with late-stage lung cancer. Qual Life Research: Int J Qual Life Aspects Treat Care Rehabilitation. 2013;22:2143–50.
Article
Google Scholar
Braun DP, Gupta D, Staren ED. Quality of life assessment as a predictor of survival in non-small cell lung cancer. BMC Cancer. 2011;11:353. https://doi.org/10.1186/1471-2407-11-353.
Article
PubMed
PubMed Central
Google Scholar
Brunelli A, Salati M, Refai M, Xiumé F, Berardi R, Mazzanti P, et al. Development of a patient-centered aggregate score to predict survival after lung resection for non–small cell lung cancer. J Thorac Cardiovasc Surg. 2013;146:385–90.e2. https://doi.org/10.1016/j.jtcvs.2013.04.007.
Article
PubMed
Google Scholar
Eser S, Göksel T, Erbaycu AE, Baydur H, Başarık B, Yanık A, et al. Comparison of generic and lung cancer-specific quality of life instruments for predictive ability of survival in patients with advanced lung cancer. SpringerPlus. 2016;5:1833. https://doi.org/10.1186/s40064-016-3492-7.
Article
PubMed
PubMed Central
Google Scholar
Fernando HC, Landreneau RJ, Heron DE, Daly BDT, Mandrekar SJ, Hillman SL, et al. Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: Results from the ACOSOG Z4032 (Alliance) multicenter randomized trial. J Thorac Cardiovasc Surg. 2015;149:718–26.
Article
Google Scholar
Fiteni F, Vernerey D, Bonnetain F, Vaylet F, Sennélart H, Trédaniel J, et al. Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients. Eur J Cancer. 2016;52:120–8. https://doi.org/10.1016/j.ejca.2015.10.004.
Article
PubMed
Google Scholar
Friis RB, Hjøllund NH, Pappot H, Taarnhøj GA, Vestergaard JM, Skuladottir H. Patient-Reported Outcome Measures Used in Routine Care Predict for Survival at Disease Progression in Patients With Advanced Lung Cancer. Clin Lung Cancer. 2021;22:e169–79. https://doi.org/10.1016/j.cllc.2020.09.014.
Article
PubMed
Google Scholar
Greer JA, Pirl WF, Jackson VA, Muzikansky A, Lennes IT, Gallagher ER, et al. Perceptions of health status and survival in patients with metastatic lung cancer. J Pain Symptom Manag. 2014;48:548–57.
Article
Google Scholar
Gupta D, Braun DP, Staren ED. Association between changes in quality of life scores and survival in non-small cell lung cancer patients. Eur J Cancer Care. 2012;21:614–22.
Article
CAS
Google Scholar
Hopkins AM, Wagner J, Modi N, Rowland A, Sorich MJ, Kichenadasse MJ. O http://orcid.org/0000-0003-1999-866X Ganessan AO-Hopkins, Ashley M; ORCID: http://orcidorg/0000-0001-7652-4378 AO-Sorich. Patient-reported outcomes as a prognostic marker of survival in patients with advanced nonsmall cell lung cancer treated with immunotherapy. Int J Cancer. 2020;147:3085–9.
Article
CAS
Google Scholar
Jeon H, Eo W, Shim B, Kim S, Lee S. Prognostic Value of Functional Assessment of Cancer Therapy-General (FACT-G) in Advanced Non-Small-Cell Lung Cancer Treated with Korean Medicine. Evidence-Based Complementary & Alternative Medicine (ECAM) 2020:1–9.
Kerstjens HAM, Hiltermann TJN, Geerse OP, Brandenbarg D, Berendsen AJ, Duijts SFA, et al. The distress thermometer as a prognostic tool for one-year survival among patients with lung cancer. Lung Cancer. 2019;130:101–7.
Article
Google Scholar
Kobayashi K, Nakaoka K, Yanagihara T, Ueda S, Saeki Y, Maki N, et al. Preoperative predictors of restoration in quality of life after surgery for lung cancer. Thorac Cancer. 2021;12:835–44.
Article
Google Scholar
Lemonnier I, Guillemin F, Arveux P, Clement-Duchene C, Velten M, Woronoff-Lemsi MC, et al. Quality of life after the initial treatments of non-small cell lung cancer: a persistent predictor for patients’ survival. Health Qual Life Outcomes. 2014;12:73. https://doi.org/10.1186/1477-7525-12-73.
Article
PubMed
PubMed Central
Google Scholar
Li T-C, Li C-I, Tseng C-H, Lin K-S, Yang S-Y, Chen C-Y, et al. Quality of life predicts survival in patients with non-small cell lung cancer. BMC Public Health. 2012;12:790.
Article
Google Scholar
Moller A, Sartipy U. Quality of life six months after lung cancer surgery is associated with long-term survival. Acta Oncol. 2012;51:1029–35.
Article
Google Scholar
Movsas B, Hu C, Sloan J, Bradley J, Komaki R, Masters G, et al. Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial. JAMA Oncol. 2016;2:359–67. https://doi.org/10.1001/jamaoncol.2015.3969.
Article
PubMed
PubMed Central
Google Scholar
O’Mahony S, Nathan S, Bonomi P, Batus M, Fidler MJ, Wells K, et al. Survival Prediction in Ambulatory Patients With Stage III/IV Non-Small Cell Lung Cancer Using the Palliative Performance Scale, ECOG, and Lung Cancer Symptom Scale. Am J Hosp palliat Care. 2016;33:374–80.
Article
Google Scholar
Pinheiro LC, Reeve BB. Investigating the prognostic ability of health-related quality of life on survival: a prospective cohort study of adults with lung cancer. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer. 2018;26:3925–32. https://doi.org/10.1007/s00520-018-4265-3.
Article
Google Scholar
Pinheiro LC, Zagar TM, Reeve BB. The prognostic value of pre-diagnosis health-related quality of life on survival: a prospective cohort study of older Americans with lung cancer. Qual Life Research: Int J Qual Life Aspects Treat Care Rehabilitation. 2017;26:1703–12. https://doi.org/10.1007/s11136-017-1515-7.
Article
Google Scholar
Pompili C, Salati M, Refai M, Berardi R, Onofri A, Mazzanti P, et al. Preoperative quality of life predicts survival following pulmonary resection in stage I non-small-cell lung cancer. Eur J Cardiothorac Surg. 2013;43:905–10.
Article
Google Scholar
Schild SE, Tan AD, Wampfler JA, Ross HJ, Yang P, Sloan JA. A new scoring system for predicting survival in patients with non-small cell lung cancer. Cancer Med. 2015;4:1334–43.
Article
Google Scholar
Sim J, Kim YA, Kim JH, Lee JM, Kim MS, Shim YM, et al. The major effects of health-related quality of life on 5-year survival prediction among lung cancer survivors: applications of machine learning. Sci Rep. 2020;10:10693. https://doi.org/10.1038/s41598-020-67604-3.
Article
CAS
PubMed
PubMed Central
Google Scholar
Spigel DR, Patel JD, Reynolds CH, Garon EB, Hermann RC, Govindan R, et al. Quality of life analyses from the randomized, open-label, phase III PointBreak study of pemetrexed-carboplatin-bevacizumab followed by maintenance pemetrexed-bevacizumab versus paclitaxel-carboplatin-bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer. J Thorac Oncol. 2015;10:353–9. https://doi.org/10.1097/JTO.0000000000000277.
Article
CAS
PubMed
Google Scholar
Stene GB, Helbostad JL, Amundsen T, Sørhaug S, Hjelde H, Kaasa S, et al. Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer. Acta Oncol. 2015;54:340–8. https://doi.org/10.3109/0284186X.2014.953259.
Article
CAS
PubMed
Google Scholar
Yun YH, Kim YA, Sim JA, Shin AS, Chang YJ, Lee J, et al. Prognostic value of quality of life score in disease-free survivors of surgically-treated lung cancer. BMC Cancer. 2016;16:505. https://doi.org/10.1186/s12885-016-2504-x.
Article
PubMed
PubMed Central
Google Scholar
Gotay CC, Kawamoto CT, Bottomley A, Efficace F. The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol. 2008;26:1355–63.
Article
Google Scholar
Montazeri A. Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health Qual Life Outcomes. 2009;7:1–21.
Article
Google Scholar
Mierzynska J, Piccinin C, Pe M, Martinelli F, Gotay C, Coens C, et al. Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review. Lancet Oncol. 2019;20:e685–98. https://doi.org/10.1016/S1470-2045(19)30656-4.
Article
PubMed
Google Scholar
Heinze G, Dunkler D. Five myths about variable selection. Transpl Int. 2017;30:6–10. https://doi.org/10.1111/tri.12895.
Article
PubMed
Google Scholar
Heinze G, Wallisch C, Dunkler D. Variable selection - A review and recommendations for the practicing statistician. Biom J. 2018;60:431–49. https://doi.org/10.1002/bimj.201700067.
Article
PubMed
PubMed Central
Google Scholar
Altman DG, Royston P. The cost of dichotomising continuous variables. BMJ. 2006;332:1080.
Article
Google Scholar
Mallett S, Royston P, Waters R, Dutton S, Altman DG. Reporting performance of prognostic models in cancer: a review. BMC Med. 2010;8:21. https://doi.org/10.1186/1741-7015-8-21.
Article
PubMed
PubMed Central
Google Scholar
Ramspek CL, Jager KJ, Dekker FW, Zoccali C, van Diepen M. External validation of prognostic models: what, why, how, when and where? Clin Kidney J. 2020;14:49–58. https://doi.org/10.1093/ckj/sfaa188.
Article
PubMed
PubMed Central
Google Scholar
Cramer-van der Welle CM, van Loenhout L, van den Borne BE, Schramel FM, Dijksman LM. “Care for Outcomes”: systematic development of a set of outcome indicators to improve patient-relevant outcomes for patients with lung cancer. BMJ Open. 2021;11:e043229. https://doi.org/10.1136/bmjopen-2020-043229.
Article
PubMed
PubMed Central
Google Scholar
Li H, Galperin-Aizenberg M, Pryma D, Simone CB, Fan Y. Unsupervised machine learning of radiomic features for predicting treatment response and overall survival of early stage non-small cell lung cancer patients treated with stereotactic body radiation therapy. Radiother Oncol. 2018;129:218–26. https://doi.org/10.1016/j.radonc.2018.06.025.
Article
PubMed
PubMed Central
Google Scholar
Yin J-Y, Li X, Li X-P, Xiao L, Zheng W, Chen J, et al. Prediction models for platinum-based chemotherapy response and toxicity in advanced NSCLC patients. Cancer Lett. 2016;377:65–73. https://doi.org/10.1016/j.canlet.2016.04.029.
Article
CAS
PubMed
Google Scholar
Pennock MM, Halmos B, Iii WRB, Cheng H, Gucalp R, Ohri N. Predictors of Early Durvalumab Discontinuation After Chemoradiotherapy for Non-Small Cell Lung Cancer. Int J Radiation Oncology*Biology*Physics. 2021;111:e448–9. https://doi.org/10.1016/j.ijrobp.2021.07.1265.
Article
Google Scholar
Postmus PE, Kerr KM, Oudkerk M, Senan S, Waller DA, Vansteenkiste J, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:iv1–21.
Article
CAS
Google Scholar
Planchard D, Popat S, Kerr K, Novello S, Smit EF, Faivre-Finn C, et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv192–237. https://doi.org/10.1093/annonc/mdy275.
Article
CAS
PubMed
Google Scholar